1. Home
  2. BEAM vs SIMO Comparison

BEAM vs SIMO Comparison

Compare BEAM & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • SIMO
  • Stock Information
  • Founded
  • BEAM 2017
  • SIMO 1995
  • Country
  • BEAM United States
  • SIMO Hong Kong
  • Employees
  • BEAM N/A
  • SIMO N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • SIMO Semiconductors
  • Sector
  • BEAM Health Care
  • SIMO Technology
  • Exchange
  • BEAM Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • BEAM 1.9B
  • SIMO 2.4B
  • IPO Year
  • BEAM 2020
  • SIMO 2005
  • Fundamental
  • Price
  • BEAM $19.45
  • SIMO $71.58
  • Analyst Decision
  • BEAM Strong Buy
  • SIMO Strong Buy
  • Analyst Count
  • BEAM 11
  • SIMO 8
  • Target Price
  • BEAM $48.90
  • SIMO $80.63
  • AVG Volume (30 Days)
  • BEAM 2.4M
  • SIMO 323.3K
  • Earning Date
  • BEAM 08-05-2025
  • SIMO 07-30-2025
  • Dividend Yield
  • BEAM N/A
  • SIMO 2.79%
  • EPS Growth
  • BEAM N/A
  • SIMO 59.19
  • EPS
  • BEAM N/A
  • SIMO 2.80
  • Revenue
  • BEAM $63,578,000.00
  • SIMO $780,733,000.00
  • Revenue This Year
  • BEAM N/A
  • SIMO $2.27
  • Revenue Next Year
  • BEAM $17.18
  • SIMO $13.72
  • P/E Ratio
  • BEAM N/A
  • SIMO $25.89
  • Revenue Growth
  • BEAM N/A
  • SIMO 10.84
  • 52 Week Low
  • BEAM $13.53
  • SIMO $37.21
  • 52 Week High
  • BEAM $35.25
  • SIMO $81.39
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 63.94
  • SIMO 56.23
  • Support Level
  • BEAM $20.75
  • SIMO $70.21
  • Resistance Level
  • BEAM $22.51
  • SIMO $75.31
  • Average True Range (ATR)
  • BEAM 1.18
  • SIMO 2.14
  • MACD
  • BEAM 0.35
  • SIMO -0.64
  • Stochastic Oscillator
  • BEAM 74.58
  • SIMO 34.15

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: